Aveanna Healthcare Holdings Inc Net Income per Employee (AVAH), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Aveanna Healthcare Holdings Inc   (NASDAQ: AVAH)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Aveanna Healthcare Holdings Inc Net Income per Employee

AVAH's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 223.17% in the third quarter 2026, year on year to cumulative value of $306 million, and with 3,500 employees, Aveanna Healthcare Holdings Inc 's income per employee grew on trailing twelve month basis to $ 87,471. The income per employee at Aveanna Healthcare Holdings Inc ' was above the company average.
The Healthcare sector has seen employees of 2 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 1137, from total ranking in previous quarter at 2102.


What is Income per Employee Ratio?






AVAH Net Income per Employee (Oct 03 2026)
III. Quarter
(Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
Y / Y Net Income Change 223.17 % 49.1 % 702.1 % 512.58 % -
Net Income per Employee (TTM) $ 87,471 78,503 74,713 64,295 21,561
AVAH's Total Ranking # 1137 # 2102 # 2058 # 1627 #
Seq. Net Income Change 12.8 % -3.27 % -76.7 % 1170.99 % -47.96 %


AVAH Net Income per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 99
Overall Market # 1137

Net Income per Employee Statistics
High Average Low
$ 78,503 $ -34,302 $ -205,533
(Jul 04 2026)   (Apr 01 2023)







Companies with similar Income per Employee for 12 month ending Oct 03 2026, within Healthcare Sector Income per Employee Income 12 month ending Oct 03 2026Number of Employees Oct 03 2026
Anaptysbio Inc   151,144.23 $ 15.719  Million 104 
Iradimed Corporation  144,481.67 $ 23.984  Million 166 
Incyte Corporation  141,846.34 $ 403.411  Million 2,844 
Resmed Inc   140,120.49 $ 1,593.170  Million 11,370 
Bio rad Laboratories Inc   137,302.01 $ 1,022.900  Million 7,450 
Carlisle Companies Incorporated  121,762.71 $ 718.400  Million 5,900 
Ani Pharmaceuticals Inc  118,691.75 $ 115.131  Million 970 
Johnson and Johnson  114,311.08 $ 16,095.000  Million 140,800 
Idexx Laboratories Inc  107,471.91 $ 1,182.191  Million 11,000 
Lemaitre Vascular Inc   99,751.15 $ 65.337  Million 655 
Protalix Biotherapeutics inc   90,933.63 $ 20.551  Million 226 
Dexcom Inc   89,432.43 $ 992.700  Million 11,100 
Aveanna Healthcare Holdings Inc   87,471.14 $ 306.149  Million 3,500 
Medpace Holdings Inc   83,520.16 $ 517.825  Million 6,200 
Escalon Medical Corp   83,162.70 $ 3.327  Million 40 
Alpha Pro Tech Ltd   76,528.46 $ 9.413  Million 123 
Beone Medicines Ltd   76,297.67 $ 915.572  Million 12,000 
Silexion Therapeutics Corp  75,785.71 $ 1.061  Million 14 
Inspire Medical Systems inc   75,555.89 $ 100.716  Million 1,333 
Jazz Pharmaceuticals Plc  71,263.32 $ 205.951  Million 2,890 
Bioventus Inc   66,100.00 $ 63.456  Million 960 
Stryker Corp  64,696.43 $ 3,623.000  Million 56,000 
Electromed Inc   60,538.07 $ 11.926  Million 197 
Boston Scientific Corporation  59,220.34 $ 3,494.000  Million 59,000 
West Pharmaceutical Services Inc   59,157.41 $ 638.900  Million 10,800 
Sanuwave Health Inc   59,054.55 $ 3.248  Million 55 
3m Company  58,578.51 $ 3,544.000  Million 60,500 
Pro dex Inc   58,398.06 $ 12.030  Million 206 
Utah Medical Products Inc  58,153.01 $ 10.642  Million 183 
Fennec Pharmaceuticals Inc   57,942.86 $ 2.028  Million 35 


Date modified: 2026-11-16T19:33:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.